hrp0089p2-p011 | Adrenals and HPA Axis P2 | ESPE2018

Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38 935 Infants

Guran Tulay , Tezel Basak , Gurbuz Fatih , Eklioglu Beray Selver , Hatipoglu Nihal , Kara Cengiz , Sahin Nuran , Simsek Enver , Cizmecioglu Filiz Mine , Ozon Alev , Bas Firdevs , Aydin Murat , Ozdemir Gulsum , Darendeliler Feyza

Background: Congenital adrenal hyperplasia (CAH) is the most common form of primary adrenal insufficiency in children. 21-hydroxylase enzyme deficiency (21-OHD) occurs in 90–95% of all cases of CAH. Despite it being a treatable condition, if unrecognized, CAH may present with life-threatening cardiovascular collapse. Mortality in the first years is reported to be higher than in the general population. Neonatal screening for CAH is effective in detecting the salt-wasting f...

hrp0084p3-752 | Diabetes | ESPE2015

The Long-Term Insulin Management with Premixed Insulin in Neonates and Infants with Diabetes

Doneray Hakan , Yalcinoz Muhammet Oktay

Objectives: To describe a new therapy protocol for the long-term insulin management in neonates and infants with diabetes.Methods: All the infants were fed with 3 hours intervals. The patients were started insulin therapy with 0.6 U/kg per day divided equally into four doses. All the insulin doses were given as premixed insulin (25% insulin lispro and 75% neutral protamine Hagedorn (NPH) insulin) when the number of breast feed was more than three during ...

hrp0086p1-p802 | Syndromes: Mechanisms and Management P1 | ESPE2016

Cognitive Evaluation in Silver Russell Children

Patti Giuseppa , Malainho Virginie Coutinho , Dellatolas Georges , Dubern Beatrice , Doummar Diane , Netchine Irene

Background: Silver-Russell syndrome (SRS) is a heterogeneous syndrome characterized by severe intrauterine and postnatal growth retardation and typical dysmorphic features. The major abnormality is the hypomethylation of paternal allele of 11p15 imprinting centre region 1. In 10% of cases a maternal uniparental disomy of chromosome 7 (UPD7) can be detected. Speech delay and learning difficulties have been reported in these patients.Objective and hypothes...

hrp0086p2-p857 | Syndromes: Mechanisms and Management P2 | ESPE2016

A Case of Familial Silver-Russell Syndrome

Hoppmann Julia , Netchine Irene , Eggermann Thomas , Jamra Rami Abou , Kiess Wieland , Pfaffle Roland

Background: Silver-Russell syndrome (SRS) is a heterogeneous condition characterized by intrauterine growth restriction, relative macrocephaly at birth, postnatal growth retardation, body asymmetry, feeding difficulties/ low body mass index and dysmorphic craniofacial features. SRS is caused by DNA hypomethylation at the H19/IGF2-imprinting control region (ICR1) on chromosome 11p15 or maternal uniparental disomy of chromosome 7 (mUPD7) in approximately 50% and 10%, respectivel...

hrp0097p1-30 | Bone, Growth Plate and Mineral Metabolism | ESPE2023

A Novel Stop Codon Mutation in Exon 6 (c.508A>T) of TRAPPC2 gene in a Patient with X-Linked Spondyloepiphyseal Dysplasia Tarda: A Case Report

Yaşar Deniz , Güleray Lafcı Naz , Karacan Küçükali Gülin , Araslı Yılmaz Aslıhan , Özkaya Dönmez Beyhan , Tahir Yazar Burak , Uçan Berna , Okur İclal , Sarıkaya Özdemir Behiye , Kurnaz Erdal , Keskin Melikşah , Savaş Erdeve Şenay

Spondyloepiphyseal dysplasia tarda (SEDT) is an inherited disorder that is diagnosed in childhood or adolescence presents with disproportionate short stature and premature osteoarthritis with frequently affecting men. Here, we described a novel nonsense mutation, c.508A>T; p.Lys170Ter, in TRAPPC2 in a Turkish patient with X-linked SEDT. The patient is a 15-year-old boy from Turkish non-consanguineous parents, presented decreasing height velocity last three years and also th...

hrp0092p3-62 | Diabetes and Insulin | ESPE2019

What Does the Insulin Pump Change in Children with Type 1 Diabetes? One-Year Clinical Follow-Up

Nezir Engin Muhammet Mesut , Arslanoglu Ilknur , Cangur Sengul

Aim: The insulin pump has an important contribution to quality of life and individualized insulin therapy. However, studies that observe clinical criteria can sometimes only reveal marginal benefits or minor differences. The use of insulin pump in our country has become recently widespread. Therefore, we aimed to share our clinical experience and to examine the effect of the pump on individual cases.Method: The records o...

hrp0086p1-p829 | Syndromes: Mechanisms and Management P1 | ESPE2016

Premature Adrenarche in Silver-Russell Syndrome: A Longitudinal Study

Ferrand Nawfel , Schweizer Roland , Binder Gerhard

Background: Silver-Russell syndrome (SRS) is reported to be associated with early adrenarche, but substantial studies are lacking.Objective and hypotheses: We aimed to determine the median age at onset of adrenarche, the prevalence of premature adrenarche as well as its causes and consequences.Method: Currently we have collected longitudinal data from 40 children with SRS seen during the last 20 years in our centre. The patients fu...

hrp0082p2-d1-418 | Growth Hormone | ESPE2014

Response to GH Treatment in Patients with Silver Russell Syndrome

Smeets C C J , Renes J S , van der Steen M , Hokken-Koelega A C S

Background: Silver Russell syndrome (SRS) is characterized by low birth weight, severe postnatal short stature and distinctive facies. In ~50% of patients, (epi)genetic alterations can be detected (~40% hypomethylation of H19 on chromosome 11, ~10% maternal uniparental disomy (UPD) 7). As SRS patients are usually born small for gestational age (SGA), they are treated with GH to improve height. However, data on long-term effects of GH treatment in SRS patients are very limited....

hrp0084p2-397 | GH & IGF | ESPE2015

Silver Russell syndrome: A Cause of Partial IGF1 Resistance?

Dufourg Marie-Noelle , Perin Laurence , Houang Muriel , Daubard Marie-Laure , Brioude Frederic , Bouc Yves Le , Netchine Irene

Background: Silver-Russell syndrome (SRS) is characterized by intrauterine and postnatal growth retardation, relative macrocephaly at birth, prominent forehead, severe feeding difficulties and body asymmetry. In around 50%, it is secondary to hypomethylation at the IGF2/H19 imprinted locus on 11p15 (11p15 LOM), and in 10% to a maternal disomy of chromosome 7 (mUPD7). Mechanisms of postnatal growth failure in SRS are not well understood.Objective and hypo...

hrp0084p2-458 | Growth | ESPE2015

Sleep Apneas in Silver Russell Syndrome: A Constant Finding

Giabicani Eloise , Boule Michele , Galliani Eva , Netchine Irene

Background: Imprinting disease such as Prader-Willi syndrome (PWS) are associated with pathological sleep due to central and obstructive apneas. No data are available concerning Silver Russell syndrome (SRS) but most patients describe day asthenia and snoring. These patients also often present with maxillo-facial malformations.Aims and objectives: We wanted to characterise sleep in SRS and evaluate GH therapy possible effect on it....